AR-C155858
AR-C155858 is a chemical compound known for its role as an inhibitor of the monocarboxylate transporter (MCT) family, specifically targeting MCT1 and MCT2. These transporters are integral membrane proteins that facilitate the transport of lactate, pyruvate, and other monocarboxylates across the plasma membrane.
Mechanism of Action[edit | edit source]
AR-C155858 functions by binding to the MCT1 and MCT2 transporters, thereby inhibiting their activity. This inhibition prevents the transport of lactate and pyruvate, which are crucial substrates in cellular metabolism, particularly under anaerobic conditions. By blocking these transporters, AR-C155858 can alter cellular metabolism, which has implications in various physiological and pathological processes.
Pharmacological Significance[edit | edit source]
The inhibition of MCT1 and MCT2 by AR-C155858 has been studied in the context of cancer metabolism. Tumor cells often rely on glycolysis followed by lactate export to sustain their rapid growth, a phenomenon known as the Warburg effect. By inhibiting lactate transport, AR-C155858 can disrupt the metabolic flexibility of cancer cells, potentially leading to reduced tumor growth and viability.
Research and Development[edit | edit source]
AR-C155858 has been utilized in various research studies to explore the role of monocarboxylate transporters in health and disease. Its ability to selectively inhibit MCT1 and MCT2 makes it a valuable tool in the study of metabolic pathways and their implications in diseases such as cancer, diabetes, and cardiovascular disorders.
Potential Therapeutic Applications[edit | edit source]
While primarily a research tool, the potential therapeutic applications of AR-C155858 are being explored. Its role in modulating cellular metabolism suggests possible uses in cancer therapy, where metabolic reprogramming is a hallmark of disease progression.
Safety and Toxicology[edit | edit source]
As with many experimental compounds, the safety and toxicological profile of AR-C155858 is not fully established. Further studies are required to determine its safety in clinical settings.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD